Cytisine for smoking cessation and heart health
Part of Heart & circulation clinical trials.
This study tests whether a medicine called cytisine can help people quit smoking and how it might affect their heart health. If you are a smoker without serious heart, liver, kidney, or immune problems, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and currently smoke.
- You have never been diagnosed with coronary artery disease (blocked heart arteries).
- You do not have an active cancer.
- You have no history of severe liver or kidney failure.
- You do not have an autoimmune disease (like lupus or rheumatoid arthritis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a medicine called cytisinicline (similar to a plant-based stop-smoking aid) affects brain activity when you see or think about smoking. It may help researchers understand how the medicine works, even if you aren't ready to quit right now.
This study tests new strategies to help people quit smoking. It may be right for you if you smoke at least 10 cigarettes a day and are not already using a quit-smoking medication.
This study tests a wellness-based smoking-cessation program (including the stop-smoking medicine varenicline) for people living with HIV who want to quit. It aims to help you reduce or stop smoking while monitoring safety, sleep, and mental health during the program.
This study tests whether combining the medication varenicline (Chantix) with a special brain stimulation treatment (TMS) can help people quit vaping or smoking nicotine. If you're motivated to quit and use nicotine daily, you may be able to join.
This study tests whether tirzepatide, a medication that helps with weight and blood sugar, can also help people quit smoking. You'd receive the medication plus standard quitting support (nicotine patches or gum and a quit-smoking app) over several months.
This study tests whether adding a gentle nerve stimulation device to nicotine replacement therapy (like patches or gum) can help people quit smoking more effectively. It may be a new option for those who have struggled to quit before.
Hear when a new Smoking Cessation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.